Avantor's Turnaround Narrative Gets Its First Real Test
Avantor Inc. (AVTR) reports second-quarter 2026 earnings before the market opens on July 29, with analysts expecting $0.19 per share—a sharp 20.83% decline from the prior year's quarter. The central question: can this life sciences and advanced technologies supplier stabilize earnings amid a challenging environment that has seen estimates revised downward throughout the year, or will the downward trajectory continue to pressure a stock that has nonetheless rallied significantly in recent months?
Part 1: Earnings Preview
Avantor Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education, government, and advanced technologies industries. The company supplies materials, equipment, instrumentation, and services across the life sciences and applied materials sectors.
Avantor is scheduled to report second-quarter 2026 results before the market opens on July 29. Analysts expect earnings of $0.19 per share on consensus estimates from 7 analysts, with a tight range between $0.19 and $0.19. The company most recently reported $0.17 per share for the first quarter of 2026. Compared to the same quarter last year when Avantor earned $0.24 per share, the current estimate represents a 20.83% year-over-year decline—a significant contraction that reflects the headwinds facing the business.
Three key themes define this earnings story:
1. Estimate Revisions and Margin Pressure: The consensus estimate has been revised down from $0.24 to $0.19 for the current quarter, signaling that analysts have grown increasingly cautious about Avantor's near-term profitability. Full-year 2026 estimates have similarly declined from $0.90 to $0.79, suggesting persistent margin pressure or weaker-than-expected demand across key end markets.
2. Demand Dynamics in Life Sciences: The life sciences sector has faced a post-pandemic normalization, with biopharma customers adjusting inventory levels and capital spending. Investors will be watching for commentary on whether demand is stabilizing or if the destocking cycle continues to weigh on results.
3. Path to 2027 Recovery: Despite the near-term challenges, analysts project a rebound in 2027 with earnings expected to grow 6.33% to $0.84 per share. The key question is whether management can articulate a credible path to that recovery, including operational improvements, cost management, and signs of end-market stabilization.
Analyst commentary ahead of the release reflects cautious positioning. With 12 of 18 analysts rating the stock a Hold and only 3 Strong Buys, the Street appears to be in wait-and-see mode, looking for evidence that the earnings trough is behind the company before turning more constructive.
Part 2: Historical Earnings Performance
Avantor has delivered a mixed earnings track record over the past four quarters, with two modest misses followed by two small beats. The company missed estimates by 4.00% in June 2025 (reporting $0.24 versus $0.25 expected) and again by 4.35% in September 2025 ($0.22 versus $0.23). The trend reversed in December 2025 with a 4.76% beat ($0.22 versus $0.21), followed by a 6.25% beat in March 2026 ($0.17 versus $0.16).
The pattern suggests Avantor has recently found its footing after a challenging mid-2025 period. The two consecutive beats indicate management may have successfully reset expectations lower, allowing the company to modestly exceed the bar. However, the absolute earnings levels have declined sequentially from $0.24 to $0.17 over the past year, underscoring the fundamental pressure on profitability even as the company has managed to beat lowered estimates.
The magnitude of surprises has been relatively modest across all four quarters, ranging from 4% to 6% in either direction. This consistency suggests analysts have maintained reasonably accurate models, with no dramatic upside or downside shocks. Heading into the July 29 report, investors should expect Avantor to be in the vicinity of the $0.19 consensus, with recent momentum suggesting a slight beat is possible if the company continues its pattern from the past two quarters.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Jun 2025 | $0.25 | $0.24 | -4.00% | Miss |
| Sep 2025 | $0.23 | $0.22 | -4.35% | Miss |
| Dec 2025 | $0.21 | $0.22 | +4.76% | Beat |
| Mar 2026 | $0.16 | $0.17 | +6.25% | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
Avantor reports before the market opens, meaning Day 0 captures the first full trading session reaction to results, while Day +1 reflects follow-through momentum.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-04-29 | -$0.01 (-0.13%) | $1.08 (13.74%) | +$0.25 (+3.18%) | $0.57 (7.20%) |
| 2026-02-11 | -$1.52 (-13.62%) | $0.96 (8.65%) | -$0.50 (-5.19%) | $0.62 (6.43%) |
| 2025-10-29 | -$3.50 (-23.21%) | $1.90 (12.57%) | -$0.53 (-4.58%) | $0.71 (6.13%) |
| 2025-08-01 | -$2.08 (-15.48%) | $1.42 (10.53%) | -$0.06 (-0.53%) | $0.41 (3.61%) |
| 2025-04-25 | -$2.57 (-16.58%) | $1.37 (8.81%) | -$0.44 (-3.40%) | $1.04 (8.00%) |
| 2025-02-07 | -$2.54 (-11.71%) | $3.36 (15.46%) | -$0.15 (-0.78%) | $1.04 (5.40%) |
| 2024-10-25 | -$0.84 (-3.61%) | $0.76 (3.27%) | +$0.21 (+0.94%) | $0.60 (2.65%) |
| 2024-07-26 | +$2.78 (+12.18%) | $1.87 (8.19%) | +$0.65 (+2.54%) | $1.23 (4.80%) |
| Avg Abs Move | 12.06% | 10.15% | 2.64% | 5.53% |
Avantor's stock has exhibited significant volatility around earnings releases, with an average absolute Day 0 move of 12.06% and an average Day 0 range of 10.15%. The direction has been predominantly negative, with five of the past eight earnings days closing lower—including three dramatic declines exceeding 15% (October 2025 at 23.21%, April 2025 at 16.58%, and August 2025 at 15.48%). The most recent report in April 2026 was notably calm by comparison, with just a 0.13% decline.
Day +1 follow-through has been more muted, averaging 2.64% with a 5.53% range. The pattern suggests initial reactions tend to be sharp and decisive, while the next session typically sees consolidation rather than continuation. The largest Day +1 move was a 3.18% gain following the April 2026 report, indicating the market took a second look and turned more positive.
Investors should prepare for potential double-digit volatility on July 29, particularly if results or guidance deviate meaningfully from expectations. The historical pattern suggests the stock is capable of sharp moves in either direction, though recent reports have been less volatile than the dramatic swings seen in late 2025.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 08/21/26 (DTE 24) |
| Expected Move | $1.36 (10.97%) |
| Expected Range | $11.04 to $13.76 |
| Implied Volatility | 54.21% |
The options market is pricing an expected move of 10.97% for the August 21 expiration, which is slightly below the stock's average historical Day 0 move of 12.06% but well within the typical range. This suggests options traders are anticipating meaningful volatility but not an outsized reaction compared to recent history. The implied move aligns with a stock that has demonstrated consistent double-digit swings around earnings, though it's notably lower than the extreme moves seen in late 2025.
Part 3: What Analysts Are Saying
Analysts maintain a cautious stance on Avantor with an average recommendation of 3.06 (Hold), reflecting a neutral-to-slightly-positive view. The consensus is unchanged from one month ago, indicating stable sentiment heading into the earnings release. Of the 18 analysts covering the stock, 3 rate it a Strong Buy, while 12 have Hold ratings and 3 assign Sell or Strong Sell ratings. The heavy concentration in Hold ratings suggests most analysts are waiting for clearer evidence of a sustainable turnaround before upgrading their views.
The average price target of $10.53 implies 15.2% downside from the current price of $12.42, a notable disconnect that reflects analyst skepticism about the stock's recent rally. The wide range of targets—from a low of $7.00 to a high of $19.00—underscores the divergent views on Avantor's prospects. The high target suggests some analysts see significant upside if the company can execute on its recovery plan, while the low target indicates others remain concerned about structural headwinds.
Sentiment has remained unchanged over the past month according to the precomputed trend indicator, suggesting analysts are holding steady in their views rather than making significant revisions ahead of the report. The below-consensus price target relative to the current stock price indicates the Street believes much of the near-term optimism may already be priced in, and that the burden is on management to deliver results that justify the recent share price appreciation.
Part 4: Technical Picture
Avantor's technical setup heading into earnings shows strong momentum, with the stock trading at $12.42—above all key moving averages. The stock sits above its 5-day ($11.58), 10-day ($11.31), 20-day ($10.82), 50-day ($9.79), 100-day ($8.89), and 200-day ($10.23) moving averages, indicating a broad-based uptrend across all timeframes.
The Barchart Technical Opinion has strengthened dramatically in recent weeks, currently registering a 72% Buy signal—up from 56% one week ago and just 24% one month ago. This sharp improvement reflects the stock's powerful rally from the low $9 range to current levels, with momentum accelerating as it broke through resistance levels.
Timeframe Analysis:
- Short-term (100% Buy): Maximum bullish signal indicates very strong near-term momentum with the stock in a clear uptrend
- Medium-term (50% Buy): Moderate buy signal suggests positive intermediate-term trend though less emphatic than the short-term reading
- Long-term (50% Buy): Moderate buy signal reflects improving longer-term trend as the stock reclaims key moving averages
Trend Characteristics: The opinion strength is rated as "Good" with direction characterized as "Strongest," indicating robust momentum in a clearly defined uptrend heading into the earnings release.
The stock has rallied approximately 27% from its 100-day moving average and 21% from its 200-day, suggesting significant appreciation in a relatively short period. This strong run-up into earnings creates a double-edged setup: positive momentum could carry the stock higher on any good news, but the extended nature of the move also means there's more room to give back gains if results disappoint.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $11.58 | 50-Day MA | $9.79 |
| 10-Day MA | $11.31 | 100-Day MA | $8.89 |
| 20-Day MA | $10.82 | 200-Day MA | $10.23 |
Key resistance may emerge near the $13.76 level (the upper end of the options expected move range), while support sits at the 20-day moving average around $10.82. The technical picture is supportive heading into earnings, with the stock in a confirmed uptrend and momentum indicators pointing higher. However, the magnitude of the recent rally—particularly the acceleration from 24% to 72% Buy signal in just one month—suggests the market has priced in considerable optimism. This creates an asymmetric risk/reward setup where meeting expectations may not be enough to sustain the rally, while any disappointment could trigger profit-taking from an overbought position.